14,500
Participants
Start Date
March 6, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
March 6, 2026
First-trimester preeclampsia screening (FMF triple test)
"An algorithm assessing the risk of developing preeclampsia combining maternal parameters, blood pressure measurement, Doppler measurements of the uterine arteries and maternal PlGF concentrations.~For women in the screening group, a Doppler study of the uterine arteries and a blood test to quantify PlGF concentrations will be performed within 2 days of randomization, allowing the risk to be calculated according to the screening test. For women with a positive screening test (i.e. predicted risk\> 1/100), a treatment with aspirin will be prescribed at 160 mg/day, started as soon as possible and before 15 WG, and taken up to 36 WG, in the absence of contraindications. For women with negative screening, usual pregnancy monitoring without aspirin will be offered."
RECRUITING
CHU Angers, Angers
RECRUITING
CHU de Bordeaux, Bordeaux
RECRUITING
Hôpital Femme Mère Enfant, Bron
RECRUITING
Hôpital Antoine Béclère, Clamart
RECRUITING
CHU Estaing, Clermont-Ferrand
RECRUITING
Hôpital Intercommunal Créteil, Créteil
RECRUITING
CHU Dijon Bourgogne, Dijon
RECRUITING
CHU Lille, Lille
RECRUITING
Hôpital de la conception et de la Timone, Marseille
RECRUITING
Hôpital Nord, Marseille
RECRUITING
CHRU de Nancy, Nancy
RECRUITING
Hôpital Femme - Maternité, Nantes
RECRUITING
Hôpital Armand Trousseau, Paris
RECRUITING
Hôpital Cochin (site Port-Royal), Paris
RECRUITING
Hôpital Saint-Joseph, Paris
RECRUITING
CHI de Poissy, Poissy
RECRUITING
Hôpital Sud Rennes, Rennes
RECRUITING
CHU Charles Nicolle, Rouen
RECRUITING
CHU Strasbourg, CMCO Schiltigheim, Strasbourg
RECRUITING
Hôpital de Hautepierre, Strasbourg
RECRUITING
Hôpital Paule de Viguier, Toulouse
RECRUITING
Hôpital Bretonneau, Tours
URC-CIC Paris Descartes Necker Cochin
OTHER
INSERM, Epopé team
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER